Common Contracts

VIA

Director Offer Letter • October 10th, 2024 • Inhibikase Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Director Offer Letter
• Filed
  October 10th, 2024
• Company
  Inhibikase Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This Director Offer Letter constitutes an agreement (“Agreement”) between you and Inhibikase Therapeutics, Inc. (“Company”) and contains all of the terms and conditions relating to your service to the Company as a Class [•] member of our Board of Directors (“Board”).

VIA EMAIL ONLY gdion@oharaco.com Ms. Gisele Dion Stoneham MA 02180

Director Offer Letter • September 1st, 2022 • Inhibikase Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Director Offer Letter
• Filed
  September 1st, 2022
• Company
  Inhibikase Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This Director Offer Letter constitutes an agreement (“Agreement”) between you and Inhibikase Therapeutics, Inc. (“Company”) and contains all of the terms and conditions relating to your service to the Company as a Class II member of our Board of Directors (“Board”).